WO2001038511A8 - Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells - Google Patents

Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells

Info

Publication number
WO2001038511A8
WO2001038511A8 PCT/EP2000/011718 EP0011718W WO0138511A8 WO 2001038511 A8 WO2001038511 A8 WO 2001038511A8 EP 0011718 W EP0011718 W EP 0011718W WO 0138511 A8 WO0138511 A8 WO 0138511A8
Authority
WO
WIPO (PCT)
Prior art keywords
sequence
resolvase
introducing
eukaryotic cells
recombination
Prior art date
Application number
PCT/EP2000/011718
Other languages
German (de)
French (fr)
Other versions
WO2001038511A2 (en
WO2001038511A3 (en
Inventor
Peter Droege
Original Assignee
Cardion Ag
Peter Droege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cardion Ag, Peter Droege filed Critical Cardion Ag
Priority to CA002394827A priority Critical patent/CA2394827A1/en
Priority to AU18239/01A priority patent/AU1823901A/en
Priority to JP2001540261A priority patent/JP2003533176A/en
Priority to EP00977566A priority patent/EP1240316A2/en
Publication of WO2001038511A2 publication Critical patent/WO2001038511A2/en
Publication of WO2001038511A3 publication Critical patent/WO2001038511A3/en
Publication of WO2001038511A8 publication Critical patent/WO2001038511A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Abstract

The invention relates to a method for the sequence-specific recombination of DNA in eukaryotic cells, comprising the following steps: introducing a first DNA sequence which contains a res sequence into a cell, introducing a copy of the first DNA sequence and performing the sequence-specific recombination using the influence of a resolvase or its derivative. The invention also relates to a method for testing topoisomerase inhibitors in a eukaryotic cell, comprising the following steps: introducing a first DNA sequence according to SEQ ID NO:1 into a cell, introducing a copy of the first DNA sequence according to SEQ ID NO:1 in direct orientation, introducing a wild-type resolvase and adding the topoisomerase inhibitors which are to be tested.
PCT/EP2000/011718 1999-11-24 2000-11-24 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells WO2001038511A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002394827A CA2394827A1 (en) 1999-11-24 2000-11-24 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells
AU18239/01A AU1823901A (en) 1999-11-24 2000-11-24 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells
JP2001540261A JP2003533176A (en) 1999-11-24 2000-11-24 Resolvese-catalyzed sequence-specific recombination of DNA in eukaryotic cells
EP00977566A EP1240316A2 (en) 1999-11-24 2000-11-24 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19956513.9 1999-11-24
DE1999156513 DE19956513A1 (en) 1999-11-24 1999-11-24 Resolvase-catalyzed, sequence-specific DNA recombination in eukaryotic cells

Publications (3)

Publication Number Publication Date
WO2001038511A2 WO2001038511A2 (en) 2001-05-31
WO2001038511A3 WO2001038511A3 (en) 2002-05-10
WO2001038511A8 true WO2001038511A8 (en) 2002-05-30

Family

ID=7930159

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/011718 WO2001038511A2 (en) 1999-11-24 2000-11-24 Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells

Country Status (6)

Country Link
EP (1) EP1240316A2 (en)
JP (1) JP2003533176A (en)
AU (1) AU1823901A (en)
CA (1) CA2394827A1 (en)
DE (1) DE19956513A1 (en)
WO (1) WO2001038511A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2739738B1 (en) 2011-08-03 2018-06-20 Ramot at Tel Aviv University, Ltd. Use of integrase for targeted gene expression

Also Published As

Publication number Publication date
AU1823901A (en) 2001-06-04
CA2394827A1 (en) 2001-05-31
WO2001038511A2 (en) 2001-05-31
DE19956513A1 (en) 2001-06-21
EP1240316A2 (en) 2002-09-18
JP2003533176A (en) 2003-11-11
WO2001038511A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
WO2002009650A3 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
GB9709728D0 (en) Single step method
WO2001098537A3 (en) Nucleic acid accessible hybridization sites
WO2002059300A3 (en) Double-stranded rna-mediated gene suppression
MXPA02006145A (en) Method for isolation of rna from formalinfixed paraffinembedded tissue specimens.
WO2002013760A3 (en) Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2001090345A3 (en) Methods and compositions for enhancing the delivery of a nucleic acid to a cell
AU7625998A (en) methods, kits and compositions for suppressing the binding of detectable probe s to non-target sequences in hybridization assays
WO2001013086A3 (en) Detection of nucleic acids
MX9803308A (en) Methods and compositions for detection of specific nucleotide sequences.
WO2000053804A3 (en) Genetic screening
Lafon‐Placette et al. Methylome of DN ase I sensitive chromatin in P opulus trichocarpa shoot apical meristematic cells: a simplified approach revealing characteristics of gene‐body DNA methylation in open chromatin state
IL148175A0 (en) Methods, compositions and kits for promoting recovery from damage to the central nervous system
WO2006055931A3 (en) Vectors for stable gene expression
DE59800215D1 (en) Microinjection method for introducing an injection substance, in particular foreign genetic material, into prokaryotic and eukaryotic cells, as well as cell compartments of the latter (plastids, cell nuclei), as well as nanopipettes for this
NZ514230A (en) A single step method for lysing cells and cleaving a fusion protein
WO2001060350A3 (en) Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation
WO2003080816A3 (en) Stem cell culture
WO2002083871A3 (en) Rapid and enzymeless cloning of nucleic acid fragments
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
WO2001034791A3 (en) Chemoreceptors in plant parasitic nematodes
TR200001046T2 (en) Positive and negative selection in homologous recombination.
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
WO2001038511A8 (en) Resolvase-catalysed, sequence-specific dna-recombination in eukaryotic cells
WO2003106625A3 (en) Hammerhead ribozymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN CZ HU ID IL IN JP KR NO PL RU SG SI SK US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2394827

Country of ref document: CA

ENP Entry into the national phase in:

Ref country code: JP

Ref document number: 2001 540261

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: C1

Designated state(s): AU CA CN CZ HU ID IL IN JP KR NO PL RU SG SI SK US ZA

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WR Later publication of a revised version of an international search report
WWE Wipo information: entry into national phase

Ref document number: 2000977566

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000977566

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000977566

Country of ref document: EP